The Frost & Sullivan research service titled U.S. COPD Market: Therapeutic Overview and Patient Outlook provides insight into marketed products, patient forecasts, and selected therapeutic approaches that are outside of current marketed areas. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: bronchodilators, anti-inflammatories, combination therapies, and novel therapeutic approaches.
